nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—muscle cancer—uterine cancer	0.209	0.371	CtDrD
Dactinomycin—germ cell cancer—uterine cancer	0.188	0.333	CtDrD
Dactinomycin—sarcoma—uterine cancer	0.167	0.296	CtDrD
Dactinomycin—ABCC6—Etoposide—uterine cancer	0.0872	0.246	CbGbCtD
Dactinomycin—ABCC6—Doxorubicin—uterine cancer	0.0595	0.168	CbGbCtD
Dactinomycin—ABCC1—Progesterone—uterine cancer	0.0575	0.162	CbGbCtD
Dactinomycin—ABCC1—Epirubicin—uterine cancer	0.033	0.0932	CbGbCtD
Dactinomycin—ABCC1—Etoposide—uterine cancer	0.0257	0.0726	CbGbCtD
Dactinomycin—ABCG2—Carboplatin—uterine cancer	0.0205	0.0579	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—uterine cancer	0.0175	0.0495	CbGbCtD
Dactinomycin—ABCG2—Etoposide—uterine cancer	0.0172	0.0486	CbGbCtD
Dactinomycin—ABCB1—Progesterone—uterine cancer	0.0139	0.0391	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—uterine cancer	0.0117	0.0331	CbGbCtD
Dactinomycin—ABCB1—Etoposide—uterine cancer	0.00621	0.0175	CbGbCtD
Dactinomycin—ABCB1—Doxorubicin—uterine cancer	0.00423	0.0119	CbGbCtD
Dactinomycin—ABCC6—Podofilox—Etoposide—uterine cancer	0.00189	1	CbGdCrCtD
Dactinomycin—Radiation injury—Doxorubicin—uterine cancer	0.0017	0.0245	CcSEcCtD
Dactinomycin—Extravasation—Carboplatin—uterine cancer	0.00146	0.0211	CcSEcCtD
Dactinomycin—Raised liver function tests—Progesterone—uterine cancer	0.00145	0.0209	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Epirubicin—uterine cancer	0.00117	0.0169	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Epirubicin—uterine cancer	0.00111	0.016	CcSEcCtD
Dactinomycin—Recall phenomenon—Epirubicin—uterine cancer	0.00111	0.016	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Doxorubicin—uterine cancer	0.00108	0.0156	CcSEcCtD
Dactinomycin—Phlebitis—Carboplatin—uterine cancer	0.00108	0.0155	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Doxorubicin—uterine cancer	0.00103	0.0148	CcSEcCtD
Dactinomycin—Recall phenomenon—Doxorubicin—uterine cancer	0.00103	0.0148	CcSEcCtD
Dactinomycin—ABCC6—renal system—uterine cancer	0.000956	0.0882	CbGeAlD
Dactinomycin—Coagulopathy—Progesterone—uterine cancer	0.000861	0.0124	CcSEcCtD
Dactinomycin—Hepatomegaly—Medroxyprogesterone Acetate—uterine cancer	0.000859	0.0124	CcSEcCtD
Dactinomycin—Proctitis—Epirubicin—uterine cancer	0.000788	0.0114	CcSEcCtD
Dactinomycin—Coagulopathy—Medroxyprogesterone Acetate—uterine cancer	0.000781	0.0113	CcSEcCtD
Dactinomycin—Necrosis—Medroxyprogesterone Acetate—uterine cancer	0.000774	0.0112	CcSEcCtD
Dactinomycin—Ascites—Etoposide—uterine cancer	0.000755	0.0109	CcSEcCtD
Dactinomycin—Hypocalcaemia—Progesterone—uterine cancer	0.000733	0.0106	CcSEcCtD
Dactinomycin—Myelosuppression—Etoposide—uterine cancer	0.000732	0.0105	CcSEcCtD
Dactinomycin—Proctitis—Doxorubicin—uterine cancer	0.000729	0.0105	CcSEcCtD
Dactinomycin—Ulcer—Medroxyprogesterone Acetate—uterine cancer	0.000643	0.00926	CcSEcCtD
Dactinomycin—Multi-organ failure—Epirubicin—uterine cancer	0.00059	0.00851	CcSEcCtD
Dactinomycin—Febrile neutropenia—Etoposide—uterine cancer	0.00057	0.00822	CcSEcCtD
Dactinomycin—Mouth ulceration—Medroxyprogesterone Acetate—uterine cancer	0.000549	0.00792	CcSEcCtD
Dactinomycin—Multi-organ failure—Doxorubicin—uterine cancer	0.000546	0.00787	CcSEcCtD
Dactinomycin—Hepatic failure—Progesterone—uterine cancer	0.000542	0.00781	CcSEcCtD
Dactinomycin—Sepsis—Medroxyprogesterone Acetate—uterine cancer	0.000527	0.0076	CcSEcCtD
Dactinomycin—ABCC1—myometrium—uterine cancer	0.000527	0.0487	CbGeAlD
Dactinomycin—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.000491	0.00708	CcSEcCtD
Dactinomycin—SLC22A5—myometrium—uterine cancer	0.000464	0.0428	CbGeAlD
Dactinomycin—Infection—Carboplatin—uterine cancer	0.000453	0.00652	CcSEcCtD
Dactinomycin—Liver function test abnormal—Progesterone—uterine cancer	0.000449	0.00648	CcSEcCtD
Dactinomycin—Hepatotoxicity—Etoposide—uterine cancer	0.000444	0.0064	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.000438	0.00632	CcSEcCtD
Dactinomycin—Necrosis—Etoposide—uterine cancer	0.000437	0.0063	CcSEcCtD
Dactinomycin—ABCG2—myometrium—uterine cancer	0.000437	0.0403	CbGeAlD
Dactinomycin—Ascites—Epirubicin—uterine cancer	0.000423	0.0061	CcSEcCtD
Dactinomycin—Dysphagia—Progesterone—uterine cancer	0.000421	0.00607	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Epirubicin—uterine cancer	0.000417	0.006	CcSEcCtD
Dactinomycin—ABCC1—uterine cervix—uterine cancer	0.00041	0.0379	CbGeAlD
Dactinomycin—Myelosuppression—Epirubicin—uterine cancer	0.00041	0.00591	CcSEcCtD
Dactinomycin—Extravasation—Etoposide—uterine cancer	0.000393	0.00567	CcSEcCtD
Dactinomycin—Ascites—Doxorubicin—uterine cancer	0.000392	0.00564	CcSEcCtD
Dactinomycin—ABCC1—decidua—uterine cancer	0.000391	0.0361	CbGeAlD
Dactinomycin—Pain—Carboplatin—uterine cancer	0.00039	0.00562	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Doxorubicin—uterine cancer	0.000385	0.00556	CcSEcCtD
Dactinomycin—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.000381	0.0055	CcSEcCtD
Dactinomycin—Myelosuppression—Doxorubicin—uterine cancer	0.000379	0.00547	CcSEcCtD
Dactinomycin—Pneumonia—Progesterone—uterine cancer	0.000377	0.00544	CcSEcCtD
Dactinomycin—ABCC1—endometrium—uterine cancer	0.000371	0.0343	CbGeAlD
Dactinomycin—Ulcer—Etoposide—uterine cancer	0.000363	0.00523	CcSEcCtD
Dactinomycin—SLC22A5—uterine cervix—uterine cancer	0.000361	0.0333	CbGeAlD
Dactinomycin—Body temperature increased—Carboplatin—uterine cancer	0.00036	0.00519	CcSEcCtD
Dactinomycin—ABCC1—mammalian vulva—uterine cancer	0.000359	0.0331	CbGeAlD
Dactinomycin—ABCC1—uterus—uterine cancer	0.000342	0.0316	CbGeAlD
Dactinomycin—ABCG2—uterine cervix—uterine cancer	0.00034	0.0314	CbGeAlD
Dactinomycin—SLC22A5—renal system—uterine cancer	0.000338	0.0312	CbGeAlD
Dactinomycin—Hepatitis—Progesterone—uterine cancer	0.000337	0.00486	CcSEcCtD
Dactinomycin—Pharyngitis—Progesterone—uterine cancer	0.000334	0.00482	CcSEcCtD
Dactinomycin—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.000331	0.00478	CcSEcCtD
Dactinomycin—SLC22A5—endometrium—uterine cancer	0.000326	0.0301	CbGeAlD
Dactinomycin—ABCG2—decidua—uterine cancer	0.000324	0.0299	CbGeAlD
Dactinomycin—Febrile neutropenia—Epirubicin—uterine cancer	0.00032	0.00461	CcSEcCtD
Dactinomycin—Erythema multiforme—Progesterone—uterine cancer	0.000318	0.00459	CcSEcCtD
Dactinomycin—Oesophagitis—Etoposide—uterine cancer	0.000313	0.00452	CcSEcCtD
Dactinomycin—Eruption—Epirubicin—uterine cancer	0.000313	0.00451	CcSEcCtD
Dactinomycin—Mouth ulceration—Etoposide—uterine cancer	0.00031	0.00447	CcSEcCtD
Dactinomycin—ABCG2—endometrium—uterine cancer	0.000307	0.0284	CbGeAlD
Dactinomycin—Folliculitis—Epirubicin—uterine cancer	0.000306	0.00441	CcSEcCtD
Dactinomycin—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.000305	0.0044	CcSEcCtD
Dactinomycin—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.000303	0.00437	CcSEcCtD
Dactinomycin—Sepsis—Etoposide—uterine cancer	0.000298	0.00429	CcSEcCtD
Dactinomycin—Alopecia—Progesterone—uterine cancer	0.000298	0.00429	CcSEcCtD
Dactinomycin—ABCG2—mammalian vulva—uterine cancer	0.000297	0.0274	CbGeAlD
Dactinomycin—Febrile neutropenia—Doxorubicin—uterine cancer	0.000296	0.00426	CcSEcCtD
Dactinomycin—Erythema—Progesterone—uterine cancer	0.000293	0.00423	CcSEcCtD
Dactinomycin—Eruption—Doxorubicin—uterine cancer	0.000289	0.00417	CcSEcCtD
Dactinomycin—Phlebitis—Etoposide—uterine cancer	0.000289	0.00417	CcSEcCtD
Dactinomycin—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000289	0.00416	CcSEcCtD
Dactinomycin—ABCG2—uterus—uterine cancer	0.000283	0.0261	CbGeAlD
Dactinomycin—Folliculitis—Doxorubicin—uterine cancer	0.000283	0.00408	CcSEcCtD
Dactinomycin—ABCC1—female gonad—uterine cancer	0.00028	0.0258	CbGeAlD
Dactinomycin—ABCC1—vagina—uterine cancer	0.000278	0.0257	CbGeAlD
Dactinomycin—Chills—Medroxyprogesterone Acetate—uterine cancer	0.000274	0.00395	CcSEcCtD
Dactinomycin—Ill-defined disorder—Progesterone—uterine cancer	0.000272	0.00392	CcSEcCtD
Dactinomycin—Hepatomegaly—Epirubicin—uterine cancer	0.000272	0.00392	CcSEcCtD
Dactinomycin—Anaemia—Progesterone—uterine cancer	0.000271	0.00391	CcSEcCtD
Dactinomycin—SLC22A5—female reproductive system—uterine cancer	0.00027	0.025	CbGeAlD
Dactinomycin—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00027	0.00389	CcSEcCtD
Dactinomycin—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000266	0.00383	CcSEcCtD
Dactinomycin—Malaise—Progesterone—uterine cancer	0.000264	0.00381	CcSEcCtD
Dactinomycin—Hepatomegaly—Doxorubicin—uterine cancer	0.000251	0.00362	CcSEcCtD
Dactinomycin—Myalgia—Progesterone—uterine cancer	0.00025	0.0036	CcSEcCtD
Dactinomycin—Discomfort—Progesterone—uterine cancer	0.000247	0.00356	CcSEcCtD
Dactinomycin—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000246	0.00355	CcSEcCtD
Dactinomycin—SLC22A5—female gonad—uterine cancer	0.000246	0.0227	CbGeAlD
Dactinomycin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000246	0.00354	CcSEcCtD
Dactinomycin—Necrosis—Epirubicin—uterine cancer	0.000245	0.00353	CcSEcCtD
Dactinomycin—SLC22A5—vagina—uterine cancer	0.000245	0.0226	CbGeAlD
Dactinomycin—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.00345	CcSEcCtD
Dactinomycin—Oedema—Progesterone—uterine cancer	0.000239	0.00345	CcSEcCtD
Dactinomycin—Infection—Progesterone—uterine cancer	0.000238	0.00343	CcSEcCtD
Dactinomycin—ABCG2—female gonad—uterine cancer	0.000232	0.0214	CbGeAlD
Dactinomycin—ABCG2—vagina—uterine cancer	0.00023	0.0213	CbGeAlD
Dactinomycin—Anorexia—Progesterone—uterine cancer	0.000228	0.00329	CcSEcCtD
Dactinomycin—Necrosis—Doxorubicin—uterine cancer	0.000227	0.00327	CcSEcCtD
Dactinomycin—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00326	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000224	0.00323	CcSEcCtD
Dactinomycin—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000223	0.00322	CcSEcCtD
Dactinomycin—Extravasation—Epirubicin—uterine cancer	0.00022	0.00318	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000218	0.00314	CcSEcCtD
Dactinomycin—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000217	0.00313	CcSEcCtD
Dactinomycin—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000215	0.00311	CcSEcCtD
Dactinomycin—ABCB1—myometrium—uterine cancer	0.000215	0.0199	CbGeAlD
Dactinomycin—Dysphagia—Etoposide—uterine cancer	0.000215	0.0031	CcSEcCtD
Dactinomycin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000212	0.00306	CcSEcCtD
Dactinomycin—Hypocalcaemia—Epirubicin—uterine cancer	0.00021	0.00303	CcSEcCtD
Dactinomycin—Decreased appetite—Progesterone—uterine cancer	0.000208	0.003	CcSEcCtD
Dactinomycin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000207	0.00298	CcSEcCtD
Dactinomycin—Fatigue—Progesterone—uterine cancer	0.000206	0.00297	CcSEcCtD
Dactinomycin—Pain—Progesterone—uterine cancer	0.000205	0.00295	CcSEcCtD
Dactinomycin—Pancytopenia—Etoposide—uterine cancer	0.000204	0.00295	CcSEcCtD
Dactinomycin—Extravasation—Doxorubicin—uterine cancer	0.000204	0.00294	CcSEcCtD
Dactinomycin—Ulcer—Epirubicin—uterine cancer	0.000203	0.00293	CcSEcCtD
Dactinomycin—Neutropenia—Etoposide—uterine cancer	0.000201	0.0029	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000198	0.00285	CcSEcCtD
Dactinomycin—Feeling abnormal—Progesterone—uterine cancer	0.000197	0.00284	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Progesterone—uterine cancer	0.000196	0.00282	CcSEcCtD
Dactinomycin—Hypocalcaemia—Doxorubicin—uterine cancer	0.000194	0.0028	CcSEcCtD
Dactinomycin—Pneumonia—Etoposide—uterine cancer	0.000193	0.00278	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00019	0.00274	CcSEcCtD
Dactinomycin—Abdominal pain—Progesterone—uterine cancer	0.000189	0.00273	CcSEcCtD
Dactinomycin—Body temperature increased—Progesterone—uterine cancer	0.000189	0.00273	CcSEcCtD
Dactinomycin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000188	0.00272	CcSEcCtD
Dactinomycin—Ulcer—Doxorubicin—uterine cancer	0.000188	0.00271	CcSEcCtD
Dactinomycin—Stomatitis—Etoposide—uterine cancer	0.000187	0.0027	CcSEcCtD
Dactinomycin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000187	0.00269	CcSEcCtD
Dactinomycin—Aplastic anaemia—Epirubicin—uterine cancer	0.000181	0.0026	CcSEcCtD
Dactinomycin—ABCC1—lymph node—uterine cancer	0.00018	0.0166	CbGeAlD
Dactinomycin—Agranulocytosis—Etoposide—uterine cancer	0.000179	0.00258	CcSEcCtD
Dactinomycin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000179	0.00258	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000177	0.00256	CcSEcCtD
Dactinomycin—Hypersensitivity—Progesterone—uterine cancer	0.000176	0.00254	CcSEcCtD
Dactinomycin—Oesophagitis—Epirubicin—uterine cancer	0.000176	0.00253	CcSEcCtD
Dactinomycin—Mouth ulceration—Epirubicin—uterine cancer	0.000174	0.00251	CcSEcCtD
Dactinomycin—Asthenia—Progesterone—uterine cancer	0.000172	0.00247	CcSEcCtD
Dactinomycin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000171	0.00247	CcSEcCtD
Dactinomycin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000171	0.00247	CcSEcCtD
Dactinomycin—ABCB1—epithelium—uterine cancer	0.000169	0.0156	CbGeAlD
Dactinomycin—ABCB1—uterine cervix—uterine cancer	0.000168	0.0155	CbGeAlD
Dactinomycin—Aplastic anaemia—Doxorubicin—uterine cancer	0.000167	0.00241	CcSEcCtD
Dactinomycin—Sepsis—Epirubicin—uterine cancer	0.000167	0.00241	CcSEcCtD
Dactinomycin—Diarrhoea—Progesterone—uterine cancer	0.000164	0.00236	CcSEcCtD
Dactinomycin—Erythema multiforme—Etoposide—uterine cancer	0.000163	0.00235	CcSEcCtD
Dactinomycin—Oesophagitis—Doxorubicin—uterine cancer	0.000163	0.00234	CcSEcCtD
Dactinomycin—Phlebitis—Epirubicin—uterine cancer	0.000162	0.00234	CcSEcCtD
Dactinomycin—Mouth ulceration—Doxorubicin—uterine cancer	0.000161	0.00232	CcSEcCtD
Dactinomycin—Flushing—Etoposide—uterine cancer	0.00016	0.00231	CcSEcCtD
Dactinomycin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00016	0.0023	CcSEcCtD
Dactinomycin—ABCB1—decidua—uterine cancer	0.00016	0.0147	CbGeAlD
Dactinomycin—SLC22A5—lymph node—uterine cancer	0.000158	0.0146	CbGeAlD
Dactinomycin—ABCB1—renal system—uterine cancer	0.000157	0.0145	CbGeAlD
Dactinomycin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000156	0.00224	CcSEcCtD
Dactinomycin—Hepatic failure—Epirubicin—uterine cancer	0.000155	0.00224	CcSEcCtD
Dactinomycin—Chills—Etoposide—uterine cancer	0.000155	0.00223	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—uterine cancer	0.000154	0.00223	CcSEcCtD
Dactinomycin—Alopecia—Etoposide—uterine cancer	0.000152	0.00219	CcSEcCtD
Dactinomycin—Vomiting—Progesterone—uterine cancer	0.000152	0.00219	CcSEcCtD
Dactinomycin—ABCB1—endometrium—uterine cancer	0.000152	0.014	CbGeAlD
Dactinomycin—Rash—Progesterone—uterine cancer	0.000151	0.00217	CcSEcCtD
Dactinomycin—Phlebitis—Doxorubicin—uterine cancer	0.00015	0.00216	CcSEcCtD
Dactinomycin—ABCG2—lymph node—uterine cancer	0.000149	0.0137	CbGeAlD
Dactinomycin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000148	0.00214	CcSEcCtD
Dactinomycin—ABCB1—mammalian vulva—uterine cancer	0.000147	0.0135	CbGeAlD
Dactinomycin—Hepatic failure—Doxorubicin—uterine cancer	0.000144	0.00207	CcSEcCtD
Dactinomycin—Lethargy—Epirubicin—uterine cancer	0.000142	0.00205	CcSEcCtD
Dactinomycin—Nausea—Progesterone—uterine cancer	0.000142	0.00205	CcSEcCtD
Dactinomycin—ABCB1—uterus—uterine cancer	0.00014	0.0129	CbGeAlD
Dactinomycin—Ill-defined disorder—Etoposide—uterine cancer	0.000139	0.00201	CcSEcCtD
Dactinomycin—Anaemia—Etoposide—uterine cancer	0.000139	0.002	CcSEcCtD
Dactinomycin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000138	0.00199	CcSEcCtD
Dactinomycin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.00197	CcSEcCtD
Dactinomycin—Malaise—Etoposide—uterine cancer	0.000135	0.00195	CcSEcCtD
Dactinomycin—Leukopenia—Etoposide—uterine cancer	0.000134	0.00194	CcSEcCtD
Dactinomycin—Lethargy—Doxorubicin—uterine cancer	0.000132	0.0019	CcSEcCtD
Dactinomycin—Liver function test abnormal—Epirubicin—uterine cancer	0.000129	0.00186	CcSEcCtD
Dactinomycin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000129	0.00186	CcSEcCtD
Dactinomycin—Discomfort—Etoposide—uterine cancer	0.000126	0.00182	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000126	0.00181	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000126	0.00181	CcSEcCtD
Dactinomycin—ABCB1—female reproductive system—uterine cancer	0.000126	0.0116	CbGeAlD
Dactinomycin—Infection—Etoposide—uterine cancer	0.000122	0.00175	CcSEcCtD
Dactinomycin—Dysphagia—Epirubicin—uterine cancer	0.000121	0.00174	CcSEcCtD
Dactinomycin—Thrombocytopenia—Etoposide—uterine cancer	0.00012	0.00173	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—uterine cancer	0.000119	0.00172	CcSEcCtD
Dactinomycin—Anorexia—Etoposide—uterine cancer	0.000117	0.00168	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000116	0.00168	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000116	0.00168	CcSEcCtD
Dactinomycin—Pancytopenia—Epirubicin—uterine cancer	0.000115	0.00165	CcSEcCtD
Dactinomycin—ABCB1—female gonad—uterine cancer	0.000114	0.0105	CbGeAlD
Dactinomycin—ABCB1—vagina—uterine cancer	0.000114	0.0105	CbGeAlD
Dactinomycin—Neutropenia—Epirubicin—uterine cancer	0.000113	0.00163	CcSEcCtD
Dactinomycin—Dysphagia—Doxorubicin—uterine cancer	0.000112	0.00161	CcSEcCtD
Dactinomycin—Pneumonia—Epirubicin—uterine cancer	0.000108	0.00156	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000107	0.00154	CcSEcCtD
Dactinomycin—Decreased appetite—Etoposide—uterine cancer	0.000106	0.00153	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—uterine cancer	0.000106	0.00153	CcSEcCtD
Dactinomycin—Fatigue—Etoposide—uterine cancer	0.000106	0.00152	CcSEcCtD
Dactinomycin—Stomatitis—Epirubicin—uterine cancer	0.000105	0.00151	CcSEcCtD
Dactinomycin—Pain—Etoposide—uterine cancer	0.000105	0.00151	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—uterine cancer	0.000104	0.0015	CcSEcCtD
Dactinomycin—Feeling abnormal—Etoposide—uterine cancer	0.000101	0.00145	CcSEcCtD
Dactinomycin—Agranulocytosis—Epirubicin—uterine cancer	0.0001	0.00145	CcSEcCtD
Dactinomycin—Pneumonia—Doxorubicin—uterine cancer	0.0001	0.00144	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Etoposide—uterine cancer	0.0001	0.00144	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	9.87e-05	0.00142	CcSEcCtD
Dactinomycin—Stomatitis—Doxorubicin—uterine cancer	9.7e-05	0.0014	CcSEcCtD
Dactinomycin—Abdominal pain—Etoposide—uterine cancer	9.68e-05	0.00139	CcSEcCtD
Dactinomycin—Body temperature increased—Etoposide—uterine cancer	9.68e-05	0.00139	CcSEcCtD
Dactinomycin—Hepatitis—Epirubicin—uterine cancer	9.66e-05	0.00139	CcSEcCtD
Dactinomycin—Pharyngitis—Epirubicin—uterine cancer	9.58e-05	0.00138	CcSEcCtD
Dactinomycin—Agranulocytosis—Doxorubicin—uterine cancer	9.29e-05	0.00134	CcSEcCtD
Dactinomycin—Erythema multiforme—Epirubicin—uterine cancer	9.13e-05	0.00132	CcSEcCtD
Dactinomycin—Hypersensitivity—Etoposide—uterine cancer	9.02e-05	0.0013	CcSEcCtD
Dactinomycin—Flushing—Epirubicin—uterine cancer	8.96e-05	0.00129	CcSEcCtD
Dactinomycin—Hepatitis—Doxorubicin—uterine cancer	8.94e-05	0.00129	CcSEcCtD
Dactinomycin—Pharyngitis—Doxorubicin—uterine cancer	8.87e-05	0.00128	CcSEcCtD
Dactinomycin—Asthenia—Etoposide—uterine cancer	8.78e-05	0.00127	CcSEcCtD
Dactinomycin—Chills—Epirubicin—uterine cancer	8.67e-05	0.00125	CcSEcCtD
Dactinomycin—Alopecia—Epirubicin—uterine cancer	8.53e-05	0.00123	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—uterine cancer	8.45e-05	0.00122	CcSEcCtD
Dactinomycin—Erythema—Epirubicin—uterine cancer	8.41e-05	0.00121	CcSEcCtD
Dactinomycin—Diarrhoea—Etoposide—uterine cancer	8.37e-05	0.00121	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—uterine cancer	8.29e-05	0.0012	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—uterine cancer	8.02e-05	0.00116	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—uterine cancer	7.9e-05	0.00114	CcSEcCtD
Dactinomycin—Ill-defined disorder—Epirubicin—uterine cancer	7.8e-05	0.00112	CcSEcCtD
Dactinomycin—Vomiting—Etoposide—uterine cancer	7.78e-05	0.00112	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—uterine cancer	7.78e-05	0.00112	CcSEcCtD
Dactinomycin—Anaemia—Epirubicin—uterine cancer	7.77e-05	0.00112	CcSEcCtD
Dactinomycin—Rash—Etoposide—uterine cancer	7.72e-05	0.00111	CcSEcCtD
Dactinomycin—Malaise—Epirubicin—uterine cancer	7.58e-05	0.00109	CcSEcCtD
Dactinomycin—Leukopenia—Epirubicin—uterine cancer	7.53e-05	0.00108	CcSEcCtD
Dactinomycin—ABCB1—lymph node—uterine cancer	7.34e-05	0.00678	CbGeAlD
Dactinomycin—Nausea—Etoposide—uterine cancer	7.27e-05	0.00105	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—uterine cancer	7.22e-05	0.00104	CcSEcCtD
Dactinomycin—Anaemia—Doxorubicin—uterine cancer	7.19e-05	0.00104	CcSEcCtD
Dactinomycin—Myalgia—Epirubicin—uterine cancer	7.16e-05	0.00103	CcSEcCtD
Dactinomycin—Discomfort—Epirubicin—uterine cancer	7.07e-05	0.00102	CcSEcCtD
Dactinomycin—Malaise—Doxorubicin—uterine cancer	7.01e-05	0.00101	CcSEcCtD
Dactinomycin—Leukopenia—Doxorubicin—uterine cancer	6.96e-05	0.001	CcSEcCtD
Dactinomycin—Oedema—Epirubicin—uterine cancer	6.86e-05	0.000989	CcSEcCtD
Dactinomycin—Infection—Epirubicin—uterine cancer	6.82e-05	0.000983	CcSEcCtD
Dactinomycin—Thrombocytopenia—Epirubicin—uterine cancer	6.72e-05	0.000968	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—uterine cancer	6.62e-05	0.000955	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—uterine cancer	6.54e-05	0.000943	CcSEcCtD
Dactinomycin—Anorexia—Epirubicin—uterine cancer	6.54e-05	0.000943	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—uterine cancer	6.35e-05	0.000915	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—uterine cancer	6.31e-05	0.000909	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.25e-05	0.000901	CcSEcCtD
Dactinomycin—Thrombocytopenia—Doxorubicin—uterine cancer	6.22e-05	0.000896	CcSEcCtD
Dactinomycin—Anorexia—Doxorubicin—uterine cancer	6.05e-05	0.000872	CcSEcCtD
Dactinomycin—Decreased appetite—Epirubicin—uterine cancer	5.96e-05	0.00086	CcSEcCtD
Dactinomycin—Fatigue—Epirubicin—uterine cancer	5.92e-05	0.000853	CcSEcCtD
Dactinomycin—Pain—Epirubicin—uterine cancer	5.87e-05	0.000846	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.78e-05	0.000834	CcSEcCtD
Dactinomycin—Feeling abnormal—Epirubicin—uterine cancer	5.65e-05	0.000815	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Epirubicin—uterine cancer	5.61e-05	0.000809	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—uterine cancer	5.52e-05	0.000796	CcSEcCtD
Dactinomycin—Fatigue—Doxorubicin—uterine cancer	5.47e-05	0.000789	CcSEcCtD
Dactinomycin—Pain—Doxorubicin—uterine cancer	5.43e-05	0.000783	CcSEcCtD
Dactinomycin—Abdominal pain—Epirubicin—uterine cancer	5.42e-05	0.000782	CcSEcCtD
Dactinomycin—Body temperature increased—Epirubicin—uterine cancer	5.42e-05	0.000782	CcSEcCtD
Dactinomycin—Feeling abnormal—Doxorubicin—uterine cancer	5.23e-05	0.000754	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—uterine cancer	5.19e-05	0.000748	CcSEcCtD
Dactinomycin—Hypersensitivity—Epirubicin—uterine cancer	5.06e-05	0.000729	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—uterine cancer	5.02e-05	0.000723	CcSEcCtD
Dactinomycin—Body temperature increased—Doxorubicin—uterine cancer	5.02e-05	0.000723	CcSEcCtD
Dactinomycin—Asthenia—Epirubicin—uterine cancer	4.92e-05	0.00071	CcSEcCtD
Dactinomycin—Diarrhoea—Epirubicin—uterine cancer	4.69e-05	0.000677	CcSEcCtD
Dactinomycin—Hypersensitivity—Doxorubicin—uterine cancer	4.68e-05	0.000674	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—uterine cancer	4.55e-05	0.000657	CcSEcCtD
Dactinomycin—Vomiting—Epirubicin—uterine cancer	4.36e-05	0.000629	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—uterine cancer	4.34e-05	0.000626	CcSEcCtD
Dactinomycin—Rash—Epirubicin—uterine cancer	4.33e-05	0.000624	CcSEcCtD
Dactinomycin—Nausea—Epirubicin—uterine cancer	4.08e-05	0.000588	CcSEcCtD
Dactinomycin—Vomiting—Doxorubicin—uterine cancer	4.04e-05	0.000582	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—uterine cancer	4e-05	0.000577	CcSEcCtD
Dactinomycin—Nausea—Doxorubicin—uterine cancer	3.77e-05	0.000544	CcSEcCtD
